Back to Screener

Healthcare

HOYA Corporation(HOCPY)

Live Price

Offline

$163.09

+0.47% today

1Y Change

+51.53%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$9.42T
Revenue Growth
+16.2%
EPS Growth
+12.8%
Dividend Yield
0.9%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

HOYA Corporation (HOCPY) is a Healthcare stock with a market cap of $9.42T and listed on OTC. The stock last traded around $163.09 and up 51.5% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of +12.8%, a dividend yield of 0.9%. What stands out right now is revenue +16.2%, EPS +12.8%, free cash flow +3.0% with operating margin 29.6% and ROIC 18.9%. The dividend is present but secondary, with a yield around 0.9%. Valuation already assumes a fairly strong business story at P/E 38.0 and price/sales 10.3. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HOCPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

HOCPY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

HOCPY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

HOCPY Max Drawdown

-16.72%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for HOCPY and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for HOCPY

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.